Aktiesnakken — April 2011
-
Det er bedre end Skod-Hansen, genmab, Novo og hvad de danske ellers hedder.
-
var det ikke 2014 el 2015
-
Newcap ændrer formål....http://www.proinvestor.com/aktienyt/547626/Selskabsmeddelelse-nr.-6--2011
-
Og indsætter Michael Vinther, Accura, i bestyrelsen.
-
Ny IR chef til genmab.... og så er der lidt nyt fra affitech også
-
Affitech A/S and Cancer Research Technology Ltd. sign exclusive antibody development deal
-
Investorer: Grækenland går konkurs http://epn.dk/okonomi2/global/europa/article2412516.ece
-
yes jeg er klar
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind